Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
Recent advances in cancer genomics have deepened the medical community ’s understanding of the molecular alterations in braintumours, more preciselysubclassifying patients into specific diagnoses.Understanding a patient ' sbraintumour mutation status in the IDH1 and ATRX genes enables more informed clinical decisions and may improve patient outcomes.The IDH1 R132H and ATRX antibodies are the latest additions to Roche ’s neuropathology portfolio, which contains 29 biomarkers.Basel, 23 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibo...
Source: Roche Media News - February 23, 2023 Category: Pharmaceuticals Source Type: news
Nomogram predicts venous thromboembolism in glioma patients
The team, led by Chuanhao Zhang from Capital Medical University in Beijing...Read more on AuntMinnie.comRelated Reading:
Nomogram assesses lymph node status better in early breast cancer
Quantitative ultrasound data could help predict preterm births
Wearable ultrasound patch collects cardiac images
Researchers develop ultrasound 'tornado' technique to treat blood clots
Combined AI system on par with radiologists for detecting breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2023 Category: Radiology Source Type: news
PET imaging effective for guiding treatment of pediatric brain cancer
PET imaging can help guide treatment decisions in children with brain tumor...Read more on AuntMinnie.comRelated Reading:
MR spectroscopy distinguishes recurrent brain tumors from necrosis
FAPI-PET shows promise over conventional PET for identifying cancer
PET tracer shows promise in imaging of brain tumors
Susceptibility-weighted MRI shows brain changes in COVID-19 patients
Machine learning, radiomics differentiates glioma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2023 Category: Radiology Source Type: news
Extent of Tumor Resection Linked to Overall Survival in Low-Grade Glioma
TUESDAY, Jan. 17, 2023 -- For patients with diffuse low-grade glioma, the extent of surgical tumor resection (EOR) is associated with overall survival (OS), with improved OS seen with EOR≥75 percent, according to a study published online Jan. 4... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2023 Category: Pharmaceuticals Source Type: news
Rise in Cervical Cancer Mortality; Drug Active in Kids' Glioma; Vit D and Melanoma
(MedPage Today) -- A California study showed a concerning increase in cervical cancer mortality among women 65 or older, the age at which routine screening is no longer recommended. (UC Davis Comprehensive Cancer Center, Cancer Epidemiology, Biomarkers... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 13, 2023 Category: Hematology Source Type: news
Extensive Resection Boosts Survival in Low-Grade Brain Tumor Extensive Resection Boosts Survival in Low-Grade Brain Tumor
Patients with diffuse low-grade glioma should undergo early, extensive resection, urge researchers reporting survival benefits from this intervention.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More Extensive Resection of Low-Grade Glioma Linked to Longer Survival
(MedPage Today) -- Patients with diffuse low-grade glioma (LGG) had longer overall survival (OS) if they underwent more extensive resection of the tumor compared with subtotal resection, a 20-year retrospective cohort study showed.
Among 392 patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 5, 2023 Category: Hematology Source Type: news
Be Aggressive With Initial Brain Tumor Surgery to Boost Survival: Study
THURSDAY, Jan. 5, 2023 – Researchers studying patients with low-grade, slow-growing brain tumors have found that more aggressive surgery may extend survival.
The trick to treating low-grade gliomas is to remove as much of them as possible soon... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 5, 2023 Category: General Medicine Source Type: news
ASTRO: Radiation therapy boosts survival rate from liver cancer
Combining radiation therapy and chemotherapy to treat patients with advance...Read more on AuntMinnie.comRelated Reading:
ASTRO issues guide on radiation therapy for glioma
ASTRO sees opportunity in CMS delay of RO Model
ASTRO releases EBRT guidelines for liver cancer treatment
CMS changes to RO Model draw ASTRO's ire
Study evaluates safety of new liver cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
UCLA researchers identify gene as potential target in treatment-resistant brain cancer
Doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane and Terry Semel Institute for Neuroscience and Human Behavior have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme.The gene, P300, enables cancer cells that have been damaged by radiation therapy to recover by rearranging DNA and initiating a molecular mechanism that refortifies tumor cells for growth and survival.In studies using mice and in human glioblastoma multiforme cells, the scientists discovered that blocking P300 disrupted its ability to set ...
Source: UCLA Newsroom: Health Sciences - October 20, 2022 Category: Universities & Medical Training Source Type: news
Research provides critical information about the size and growth speed of gliomas
ROCHESTER, Minn. — An important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum Research Institute (LTRI) at Mount Sinai Hospital in Toronto and Mayo Clinic Comprehensive Cancer Center and Mayo Clinic Center for Individualized Medic ine. The study, published in the journal Science, provides a rare window into the biological changes behind glioma development. Researchers found that animal models who carry a change in… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 7, 2022 Category: Hospital Management Source Type: news
Maternal Diabetes a Risk Factor for Cancer in Children? Maternal Diabetes a Risk Factor for Cancer in Children?
Prenatal exposure to diabetes may raise the risk of glioma in children, an analysis suggests; however, experts urged caution in interpreting the findings.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
ASTRO Offers Guidance on RT for IDH - Mutant Diffuse Grade 2, 3 Glioma
Guideline recommendations support reduction in volume of brain irradiation while attempting to maximize disease control (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 19, 2022 Category: Cancer & Oncology Tags: Oncology, Radiology, Journal, Source Type: news
ASTRO Offers Guidance on RT for IDH-Mutant Diffuse Grade 2, 3 Glioma
MONDAY, Sept. 19, 2022 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the September-October issue of Practical Radiation Oncology, recommendations are presented for the use of radiation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2022 Category: Pharmaceuticals Source Type: news
ASTRO applauds legislation on 'real-time' prior authorizations
The American Society for Radiation Oncology (ASTRO) is applauding passage o...Read more on AuntMinnie.comRelated Reading:
ASTRO issues guide on radiation therapy for glioma
CMS officially postpones changes to radiation therapy payments
Biden administration confirms Bertagnolli to lead NCI
ASTRO recognizes fellows class for 2022
ASTRO sees opportunity in CMS delay of RO Model (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2022 Category: Radiology Source Type: news
